Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group.
Powles
T
T
Shamash
J
J
Berney
D
D
Oliver
R T D
RT
D002166:Camptothecin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D019008:Drug Resistance, Neoplasm; D005858:Germany; D006801:Humans; D000077146:Irinotecan; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D009373:Neoplasms, Germ Cell and Embryonal / Q000188:drug therapy* / Q000473:pathology; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000556:secondary
D000077146:Irinotecan; D002945:Cisplatin; D002166:Camptothecin